Health functional food-related stocks showed a clearly mixed performance during the afternoon session on the 16th. While buying interest flowed into some stocks, profit-taking selling emerged in others, resulting in pronounced differentiation among individual stocks.

As of the afternoon, Nutri maintained its upward trend, trading at 4,040 won, up 125 won (3.19%) from the previous trading day, showing relative strength among health functional food-related stocks. Bifido also posted a 3.93% gain to 2,515 won, displaying concurrent strength. Additionally, HL Science (2.42%), Cosmax NBT (2.01%), and Green Cross WellBeing (1.71%) rode an upward trend, attracting investor attention, while Natural Endotech and Farmsville also recorded modest gains.

On the other hand, FromBio traded at 774 won, down 7.31%, marking the largest decline of the day. Moaralife Plus (-4.25%), Synergy Innovation (-4.00%), RPBio (-3.42%), and BL Farm Tech (-3.40%) also failed to escape the downward trend. Novarex and Caregen also showed weakness in the 2% range.

Regarding market outlook, the health functional food market is maintaining steady growth, driven by aging demographics and expanding health management demand. With consumer interest rising for a variety of functional products targeting immunity, gut health, and weight management, related companies continue to expand their businesses.

However, the market advises that thorough analysis of individual stocks' competitiveness and growth strategies is necessary, as earnings volatility may occur due to raw material prices, consumer sentiment, and changes in distribution channels. The industry projects that not only the domestic market but also the expansion of overseas exports and the performance of new product launches will serve as key variables determining the future earnings and stock price trends of health functional food-related companies.

[※ This article was written with the assistance of an artificial intelligence (AI) analysis tool, and the final content was provided through an editorial process. The content included in this article is for informational purposes only and does not constitute a buy or sell recommendation for any specific stock or financial product. Investment decisions and their associated responsibilities rest entirely with the investor. Actual results may vary depending on market conditions.]